Vbl Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Modi Inisraelfounded In 2000The Company Focuses On Developing Targeted Therapies For Immune Inflammatory Diseases And Canceraiming To Address Unmet Medical Needs With First In Class Treatments One Of Vbl S Lead Candidates Is Vb 601Which Employs Proprietary Monocyte Targeting Technologymttto Manage Chronic Inflammationthis Technology Specifically Targets Monocytesimmune Cells That Play A Role In The Progression Of Inflammatory Diseasesvbl Therapeutics Is Dedicated To Advancing Vb 601 Through Clinical Developmentparticularly For Patients With Immune Inflammatory Conditions The Company Is Publicly Traded On Nasdaq Under The Ticker Symbol Vbltvbl Therapeutics Has Previously Partnered With Nano Carrier To Enhance Its Development Effortsemphasizing Its Commitment To Independent Advancement Of Its Mtt Platform
